E71.51
Disorders of peroxisome biogenesis
Clinical Classification Guidelines
Inclusion Terms
- Group 1 peroxisomal disorders
Excludes Type 1
- Refsum's disease (G60.1)
Medical Intelligence & Overview
Disorders of peroxisome biogenesis are rare genetic conditions that affect the formation and function of peroxisomes inside cells. Peroxisomes are tiny structures vital for breaking down certain fatty acids and toxins, and for supporting overall cell health. When these organelles don't develop properly, it can lead to a range of health issues, often affecting the nervous system, liver, and other organs. These conditions are classified as Group 1 peroxisomal disorders under the ICD-10 system, with E71.51 indicating a specific diagnosis related to peroxisome formation problems.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents that disrupt the normal development of peroxisomes Defects in genes responsible for the biogenesis and maintenance of peroxisomes In some cases, environmental factors do not directly cause but may influence the severity of symptoms if genetic mutations are present
Key Symptoms: Developmental delays and intellectual disabilities Muscle weakness and coordination problems Liver dysfunction, including enlarged liver Vision and hearing issues Seizures in some cases Nerve damage leading to peripheral neuropathy Progressive neurological decline Poor growth and failure to thrive in infants
Diagnostic & Treatment
Diagnosis Path: Diagnosing disorders of peroxisome biogenesis involves a combination of clinical evaluation and laboratory tests. Blood tests may reveal abnormal levels of certain lipids and very-long-chain fatty acids. Genetic testing can identify mutations in specific genes associated with peroxisome formation. Additional assessments such as brain imaging and biopsies of liver tissue may be performed to evaluate the extent of organ involvement and cellular abnormalities.
Treatment Protocols: There is currently no cure for disorders of peroxisome biogenesis. Treatment focuses on managing symptoms and supporting affected organs. Approaches include, but are not limited to:
Clinical Advice & FAQs
Billing Guidance
Is E71.51 a billable ICD-10 code?
Yes, E71.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.51?
Clinical documentation must specify the nature of Disorders of peroxisome biogenesis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference